The U.S. Court of Appeals for the First Circuit, in United States v. Regeneron, has joined the Sixth and Eighth Circuits in adopting the “but-for” standard to find that a violation of the Anti-Kickback Statute (AKS) triggers...more
7/29/2025
/ Anti-Kickback Statute ,
Appeals ,
Appellate Courts ,
Bribery ,
Causation ,
Civil Liability ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Funding ,
Food and Drug Administration (FDA) ,
Fraud ,
Healthcare Fraud ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
SCOTUS ,
Statutory Interpretation